Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
HALO
SMMT
Add up to 3 more stocks
HALO
Halozyme Therapeutics, Inc.
+1.30%
$109.72+1.41Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$13.01B
52W Range
$61.23 - $116.85
SMMT
Summit Therapeutics Inc.
+0.23%
$17.31+0.04Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$13.81B
52W Range
$12.07 - $29.23
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 32.75 | N/A |
| Forward P/E | 13.04 | N/A |
| PEG Ratio | 1.43 | N/A |
| P/B Ratio | 90.66 | 21.92 |
| P/S Ratio | 7.82 | N/A |
| P/FCF Ratio | 16.14 | N/A |
| EV/EBITDA | 14.22 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 78.2% | 0.0% |
| Operating Margin | 56.8% | 0.0% |
| Net Margin | 24.9% | 0.0% |
| ROE | 288.1% | -135.9% |
| ROA | 16.1% | -113.8% |
| ROIC | 27.4% | -134.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.71 | 6.96 |
| Quick Ratio | 2.31 | 6.96 |
| Debt/Equity | 14.95 | 0.03 |
| Interest Coverage | 45.03 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.